BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23615537)

  • 21. P2 purinergic receptors signal to glycogen synthase kinase-3beta in astrocytes.
    Neary JT; Kang Y
    J Neurosci Res; 2006 Aug; 84(3):515-24. PubMed ID: 16810687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SRC-family tyrosine kinases in wound- and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells.
    Xu KP; Yin J; Yu FS
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2832-9. PubMed ID: 16799022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells.
    Asano S; Ono A; Baba K; Uehara T; Sakamoto K; Hayata-Takano A; Nakazawa T; Yanamoto S; Tanimoto K; Hashimoto H; Ago Y
    J Pharmacol Sci; 2024 Mar; 154(3):139-147. PubMed ID: 38395514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways.
    Park JH; Ryu JM; Han HJ
    J Cell Physiol; 2011 Jan; 226(1):267-75. PubMed ID: 20658539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrogen sulfide inhibits abnormal proliferation of lymphocytes via AKT/GSK3β signal pathway in systemic lupus erythematosus patients.
    Han Y; Zeng F; Tan G; Yang C; Tang H; Luo Y; Feng J; Xiong H; Guo Q
    Cell Physiol Biochem; 2013; 31(6):795-804. PubMed ID: 23735868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
    Liu Y; Hock JM; Sullivan C; Fang G; Cox AJ; Davis KT; Davis BH; Li X
    J Cell Biochem; 2010 Dec; 111(6):1546-55. PubMed ID: 20862710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Src regulates cell cycle protein expression and renal epithelial cell proliferation via PI3K/Akt signaling-dependent and -independent mechanisms.
    Xing J; Zhang Z; Mao H; Schnellmann RG; Zhuang S
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F145-52. PubMed ID: 18434386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of Cx43 phosphorylation in 5'-N-ethylcarboxamide-induced migration and proliferation of mouse embryonic stem cells.
    Kim MO; Lee YJ; Han HJ
    J Cell Physiol; 2010 Jul; 224(1):187-94. PubMed ID: 20232318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cells.
    Lee J; Ju J; Park S; Hong SJ; Yoon S
    Nutr Cancer; 2012; 64(1):153-62. PubMed ID: 22098108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. beta-catenin mediates insulin-like growth factor-I actions to promote cyclin D1 mRNA expression, cell proliferation and survival in oligodendroglial cultures.
    Ye P; Hu Q; Liu H; Yan Y; D'ercole AJ
    Glia; 2010 Jul; 58(9):1031-41. PubMed ID: 20235220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
    Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
    Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
    Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERK1/2 and Akt pathway activated during (3R,6R)-bassiatin(1)-induced apoptosis in MCF-7 cells.
    Meng L; Tao H; Dong G; Yang T; Zhang W; Zhu W; Huang C
    Cell Biol Int; 2012 Apr; 36(4):345-8. PubMed ID: 22150072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
    Zhao Y; Chen X; Cai L; Yang Y; Sui G; Fu S
    J Cell Physiol; 2010 Oct; 225(1):168-73. PubMed ID: 20458733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel indoloquinoline derivative, IQDMA, inhibits STAT5 signaling associated with apoptosis in K562 cells.
    Yang SH; Chien CM; Su JC; Chen YL; Chang LS; Lin SR
    J Biochem Mol Toxicol; 2008; 22(6):396-404. PubMed ID: 19111001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells.
    D'Alessio A; De Luca A; Maiello MR; Lamura L; Rachiglio AM; Napolitano M; Gallo M; Normanno N
    Breast Cancer Res Treat; 2010 Sep; 123(2):387-96. PubMed ID: 19946741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
    Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
    Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High glucose regulates cyclin D1/E of human mesenchymal stem cells through TGF-beta1 expression via Ca2+/PKC/MAPKs and PI3K/Akt/mTOR signal pathways.
    Ryu JM; Lee MY; Yun SP; Han HJ
    J Cell Physiol; 2010 Jul; 224(1):59-70. PubMed ID: 20232305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
    Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
    Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.